Search Results 4061-4070 of 9748 for cannabis
At the top of the hour we'll also hear from David Ahlquist, M.D., a Mayo Clinic gastroenterologist and co-inventor of the Cologuard test. This high-tech home ...
ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest oncology findings at the 2025 American Society of Clinical ...
More than 45-percent of American men are infected with genital HPV, according to a recent study published in JAMA Oncology. The study also found the HPV[...] By ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This is a phase II trial that will study how well tucatinib (ONT-380) and trastuzumab work in treating patients with colorectal cancer with a specific genetic ...
ROCHESTER, Minn. — Mayo Clinic Platform_Accelerate celebrated the program's most recent cohort of health tech startups, including 15 innovative businesses from ...
Phoenix — Heart disease is the leading cause of death worldwide. One of the most common types of cardiovascular disease is a heart attack. In[...].
This is an international, multicenter, open-label, long-term safety study of ZX008 in pediatric and young adult subjects with Dravet syndrome who have ...
2024 marks a pivotal year for advancing artificial intelligence (AI) solutions in healthcare, requiring multidisciplinary teamwork and scientific rigor to ...
Data Analytics and AI for Advanced Liver Disease: Vijay Shah, Patrick Kamath, Douglas Simonetto, Alina Allen · Developmental Endoscopy Laboratory: Elizabeth ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.